Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status

Fig. 2

Classification of BRCA1 mutation and tumor BRCA1 promoter methylation. In total, 399 patients were classified into four groups: BRCA1-non-altered (n = 127), tumor BRCA1-PM (n = 134 + 12 = 146), sBRCA1m (n = 19 + 2 = 21), and gBRCA1m (n = 94 + 11 = 105). Abbreviations: ER, estrogen receptor; PR, progesterone receptor; BRCA1-PM, BRCA1 promoter methylation; sBRCA1m, somatic BRCA1 mutation; gBRCA1m, germline BRCA1 mutation; BRCA1-non-altered, without germline BRCA1 mutation, without somatic BRCA1 mutation, and without tumor BRCA1 promoter methylation

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us